Insulin glargine biosimilar (Wanbang Biochemical) | Interleukin Related interleukin-related.com

Product Name :
Insulin glargine biosimilar (Wanbang Biochemical)

Search keywords :
Insulin glargine

drugId :
null

Target Vo:
Insulin receptor

Target Vo Short Name :
INSR

Moa_Name:
Insulin receptor agonists

First Approval Country :
Mainland China

First Approval Date Filter:
2022

Origin Company_Name :
Wanbang Biopharmaceuticals Co Ltd

Active Company_Name :
Wanbang Biopharmaceuticals Co Ltd

Active Indication_Name:
Diabetes Mellitus

In Active Indication_Name:
Diabetes Mellitus, Type 2

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Proteasome 20S LMP7 Antibody
Phospho-CREB (Ser133) Antibody (YA209)
Phospho-CDC37 (Ser13) Antibody: Phospho-CDC37 (Ser13) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44 kDa, targeting to Hsp90 co-chaperone Cdc37 (CDC37). It can be used for WB,IP assays in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts